Company Type: MedTech

Stem Cell Educator (SCE) Therapy for Diabetes addresses the cost burden of patients by an average of $9,000 per year per patient in total costs (in the US in 2020) and reduction in insulin dependency which is painful when administered to patient.  There are currently no known closest competitors to SCE Therapy for diabetes under the same technology class and pricing. The alternatives are in the autoimmune cell therapy space with treatment cost above USD150,000 and lagging behind in FDA approval. SCE Therapy treatment is affordable about USD50K, with 2 infusions at efficacy of 70% to 80% (current claim) although there is a potential for cure to be substantiated by clinical evidence. BioXL Asia holds exclusive rights to commercialise SCE Therapy in Asia, including Australia and Singapore as one of the hubs

Company Type: Digital Health

KeyReply is an AI patient engagement and workflow automation platform that addresses issues like staff shortages, patient no-shows, and patient non-adherence.

Key use cases include care navigation, patient nudging and education, automating patient and administrative services, and population health.

Since 2019, KeyReply has held accreditation from the Ministry of Health (Synapxe) in Singapore and works with 60% of public hospitals. This endorsement underscores their credibility, as these organizations are renowned for their high reputation and stringent standards.

Company Type: BioTech

SG Diagnostics is a Singapore-based ISO13485 certified In Vitro Diagnostic (IVD) company, established with a clear mission to improve people’s life through quality point-of-care diagnostics. SG Diagnostics' dedicated scientists' team are committed to bringing innovative and quality solutions in both chronic disease and infectious disease management. 

This includes a diabetic monitoring kit that tracks the level of Hemoglobin A1c (HbA1c) - an indication of blood glucose level over 2 to 3 months, allowing for less frequent visits to the doctor. The second device is a cholesterol monitoring kit that allows for testing of lipid profile through a drop of blood that is already available in Singapore pharmacies. 

Company Type: BioTech

Trisafe Healthtech, a Singapore-based biotech spin-off of A*STAR, strategically collaborates with the National Skin Centre to pioneer innovative skincare solutions. We specialize in developing polyionene-infused products designed to combat prevalent and persistent skin issues caused by bacterial, fungal, or viral infections, such as athlete’s foot, diabetic foot, and eczema.

These conditions are known for their high prevalence, prolonged duration, and recurring episodes. Traditional small molecular therapeutic drugs often present challenges such as irritating, sensitizing, and drug-resistant properties. In contrast, our macromolecular polymer technology offers a safer and more effective approach to breaking the cycle of recurrence.